Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

6.13
-0.2100-3.31%
Post-market: 6.230.1000+1.63%19:30 EDT
Volume:835.40K
Turnover:5.21M
Market Cap:118.56M
PE:-1.01
High:6.68
Open:6.59
Low:6.06
Close:6.34
52wk High:20.56
52wk Low:6.06
Shares:19.34M
Float Shares:17.42M
Volume Ratio:1.12
T/O Rate:4.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.16
PE(LYR):-1.04

Loading ...

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 05

Corbus Pharma CMO Nicacio Leonardo Viana Files Initial Beneficial Ownership Statement

Reuters
·
Aug 05

Corbus reports last patient completes last visit in CANYON-1 trial

TIPRANKS
·
Aug 04

Corbus Says Phase 1b Canyon-1 Obesity Trial of CRB-913 Reaches Last Patient Last Visit

Reuters
·
Aug 04

Corbus Pharmaceuticals Announces Last Patient Last Visit in Canyon-1 Study of Crb-913 for the Treatment of Obesity

THOMSON REUTERS
·
Aug 04

Corbus Pharmaceuticals Holdings Inc Expected to Post a Loss of $1.26 a Share - Earnings Preview

Reuters
·
Jul 31

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 30

Corbus Pharmaceuticals announces FDA clearance to initiate TEMPO-1 trial

TIPRANKS
·
Jul 28

Corbus Pharmaceuticals Announces FDA Clearance to Initiate Tempo-1 Registrational Study of Crb-701 in Patients with 2L Oropharyngeal Cancer

THOMSON REUTERS
·
Jul 28

Corbus Pharmaceuticals Holdings Inc: Expects to Initiate Enrollment in Tempo-1 in September 2026

THOMSON REUTERS
·
Jul 28

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

GlobeNewswire
·
Jul 28

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 25

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 23

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 21

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 18

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 17

Corbus Pharmaceuticals Holdings Inc. Stock Slides 6.6%, Underperforms Peers

Dow Jones
·
Jul 14

Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market

Dow Jones
·
Jul 10

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 09